Myriam Curet McAdams - 21 Oct 2022 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Donna Spinola For: Curet, Myriam
Issuer symbol
ISRG
Transactions as of
21 Oct 2022
Net transactions value
-$299,456
Form type
4
Filing time
24 Oct 2022, 16:46:01 UTC
Previous filing
26 Sep 2022
Next filing
02 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $333,247 +2,000 +922% $166.62 2,217 21 Oct 2022 Direct F1
transaction ISRG Common Stock Sale $419,561 -2,000 -90% $209.78 217 21 Oct 2022 Direct F1, F2
transaction ISRG Common Stock Options Exercise $1,045,540 +6,000 +2765% $174.26 6,217 21 Oct 2022 Direct F1
transaction ISRG Common Stock Sale $1,258,682 -6,000 -97% $209.78 217 21 Oct 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,000 -19% $0.000000 8,500 21 Oct 2022 Common Stock 2,000 $166.62 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -6,000 -33% $0.000000 12,000 21 Oct 2022 Common Stock 6,000 $174.26 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 10, 2023.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $207.08 to $212.46 as follows: 1,290 shares sold at $207.08 to $208.08; 1,411 shares sold at $208.09 to $209.09; 1,600 shares sold at $209.49 to $210.41; 3,319 shares sold at $210.50 to $211.45 and 380 shares sold at $211.70 to $212.46. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.